Centro Hospitalar e Universitario de Coimbra, EPE

Coimbra 3041-853

0 studies enrolling now · 13 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Atopic Dermatitis, Autologous Stem Cell Transplant, Carcinoma, Non-Small-Cell Lung, Colitis, Ulcerative, Coronary Heart Disease (CHD), Crohn Disease, Crohn's Disease, Macular Edema, Multiple Myeloma, Multiple Sclerosis, Neurodegenerative Diseases

Studies at this site

Pyruvate Kinase Deficiency Global Longitudinal Registry — Running, not enrolling
A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon) — Completed
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
Continuation Study for Latozinemab — Stopped early
A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) — Completed
A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant — Completed
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease — Stopped early
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease — Completed
Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO — Stopped early
Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS) — Completed
A Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung Cancer — Stopped early
An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis — Completed
Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease — Stopped early